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AbstrACt
Objective To describe changes in cardiovascular risk 
factors and in the estimated 10-year risk of acute 
myocardial infarction (AMI) or cerebral stroke (CS) between 
SAMINOR 1 (2003–2004) and SAMINOR 2 (2012–2014), 
and explore if these changes differed between Sami and 
non-Sami.
Design Two cross-sectional surveys.
setting Inhabitants of rural Northern Norway.
Participants Participants were aged 40–79 years and 
participated in SAMINOR 1 (n=6417) and/or SAMINOR 2 
(n=5956).
Primary outcome measures Generalised estimating 
equation regressions with an interaction term were used 
to estimate and compare changes in cardiovascular risk 
factors and 10-year risk of AMI or CS between the two 
surveys and by ethnicity.
results Mean cholesterol declined by 0.50, 0.43 
and 0.60 mmol/L in women, Sami men and non-Sami 
men, respectively (all p<0.001). Sami men had a 
small decline in mean high-density lipoprotein (HDL) 
cholesterol and an increase in mean triglycerides (both 
p<0.001), whereas non-Sami showed no change in these 
variables. Non-Sami women had an increase in mean 
HDL cholesterol (p<0.001) whereas Sami women had 
no change. Triglycerides did not change in non-Sami 
and Sami women. Systolic and diastolic blood pressure 
declined by 3.6 and 1.0 mm Hg in women, and 3.1 
and 0.7 in men, respectively (all p<0.01). Mean waist 
circumference increased by 6.7 and 5.9 cm in women and 
men, respectively (both p<0.001). The odds of being a 
smoker declined by 35% in women and 46% in men (both 
p<0.001). Estimated 10-year risk of AMI or CS decreased 
in all strata of sex and ethnicity (p<0.001), however, Sami 
women had a smaller decline than non-Sami did.
Conclusions Independent of ethnicity, there was a 
decline in mean cholesterol, blood pressure, smoking, 
hypertension (women only) and 10-year risk of AMI or CS, 
but waist circumference increased. Relatively minor ethnic 
differences were found in changes of cardiovascular risk 
factors.
IntrODuCtIOn
Since the 1970s, a favourable decline in 
systolic blood pressure,1–4 total cholesterol5–7 
and smoking8 has been reported for the 
adult population across different regions of 
Western Europe. This decline is probably due 
to changes in lifestyle and diet,7 9 10 in addition 
to use of medication.1 5 In Norway, this decline 
has coincided with a decrease in cardiovas-
cular mortality and an increased prevalence 
of obesity and a sedentary lifestyle.11 
The Sami is an indigenous people living in 
Sápmi, that is, the northern parts of Norway, 
Sweden, Finland and the Kola Peninsula in 
the Russian Federation. There are no official 
strengths and limitations of this study
 ► We used generalised estimating equation regression 
to account for overlapping samples.
 ► We used self-reported measures to categorise par-
ticipants into ethnic groups, including questions on 
self-perceived ethnicity, ethnic background and lan-
guage use.
 ► Due to lack of ethnic identifiers in national registries, 
we do not know if participation differs by ethnicity.
 ► We have an acceptable participation rate in both 
surveys.
 ► We lack information about the use of lipid-lowering 
drugs.
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population records on the Sami population, but data 
from the 1970 national census roughly estimated that 
there were 40 000 Sami in Norway,12 whereas 55 000 is the 
population number that the Sami Parliament uses when 
considering subsidy schemes for business development.13 
In 2017, approximately 17 000 Sami adults were enrolled 
in the electoral register to the Sami Parliament in Norway, 
which gives them the right to vote and be elected.14 The 
Sami people have unique cultures and languages, but 
these have partly vanished or at least declined in practice, 
due to structural assimilation that occurred from 1850 to 
1960.15 The Norwegian part of Sápmi is also inhabited by 
Norwegians and Kvens, the latter of whom are descen-
dants of Finnish-speaking people that came from Sweden 
and Finland to Northern Norway in the 1700s and 1800s.16
Surveys from Norway have concluded that there are no 
or only minor differences in cardiovascular risk factors 
and morbidity between the Sami and non-Sami in rural 
regions.17–21 However, knowledge is lacking on changes 
in conventional cardiovascular risk factors. Thus, this 
study aimed to describe changes in cardiovascular risk 
factors and in the estimated 10-year risk of acute myocar-
dial infarction (AMI) or cerebral stroke (CS) between 
SAMINOR 1 (2003–2004) and SAMINOR 2 (2012–2014), 
and explore if these changes differed between Sami and 
non-Sami.
MethODs
We used data from two cross-sectional surveys of the 
Population-based Study on Health and Living Condi-
tions in Regions with Sami and Norwegian Populations 
(The SAMINOR Study): the SAMINOR 1 Survey carried 
out in 2003–2004 (SAMINOR 1) and the SAMINOR 2 
Clinical Survey carried out in 2012–2014 (SAMINOR 
2). SAMINOR 1 was a collaboration between the Centre 
for Sami Health Research at UiT The Arctic Univer-
sity of Norway and the Norwegian National Institute of 
Public Health,22 whereas SAMINOR 2 was performed 
by the former only.23 Participants were invited from 10 
municipalities (figure 1) that, according to the popula-
tion census from 1970,12 had high proportions of Sami 
inhabitants. Invitations were mailed to all who were 
aged 40–79 years and were registered as inhabitants in 
the 10 municipalities by the National Registry. In total, 
11 518 and 12 455 received an invitation to SAMINOR 1 
and SAMINOR 2, respectively. Participation was volun-
tarily and clinical examinations in each municipality were 
conducted within a period of 1–7 weeks, depending on 
the population size. Our analyses were restricted to those 
who attended clinical examinations, gave blood samples 
and answered the self-administered questionnaires.
Participant and public involvement
Participants that had pathological findings from the clin-
ical examination, were recommended to contact their 
primary physician. In emergency situations, participants 
were sent directly to the local health centre or the nearest 
hospital.
Before and after the surveys, the Centre for Sami 
Health Research had consultations with the Sami Parlia-
ment, Sami researchers and health workers in Sami core 
areas to identify the needs of the Sami community. Results 
from the surveys were reported to decision makers at the 
municipal and regional levels, and to the Sami Parlia-
ment and national health authorities. The population was 
informed through popular science forums, meetings and 
lectures.
study sample
There were 6550 (56.9%) and 6004 (48.2%) individuals 
who attended the clinical examinations in SAMINOR 1 
and SAMINOR 2, respectively. If information on ethnicity 
was lacking in one of the surveys, ethnicity information 
given in the other survey was used, as Sami ethnicity 
is found to be stable.24 This strategy was valuable for 
the SAMINOR 1 sample, as ethnicity information was 
lacking for some participants due to the study design.22 
In SAMINOR 1, we categorised 69 out of 201 by using 
ethnicity information from SAMINOR 2: 7 non-Sami 
and 62 Sami. In SAMINOR 2, 96 had missing data on 
ethnicity and we categorised 58: 37 non-Sami and 21 
Figure 1 Inhabitants aged 40–79 years living in these 10 
municipalities in the Norwegian part of Sápmi were invited to 
the SAMINOR 1 and SAMINOR 2 surveys. Region 1 includes 
Kautokeino and Karasjok, region 2 includes Nesseby, Tana 
and Porsanger, and region 3 includes Kåfjord, Lyngen, 
Storfjord, Skånland and Evenes. There are no copyrights 
attached to this figure. The figure is designed for this article 
by one of the co-authors, Marita Melhus, Centre for Sami 
Health Research at UiT The Arctic University of Norway. 
The figure is based on a raw map of Norway made by the 
Norwegian Mapping Authority, merged with a map of Europe 
that is available to the public domain at Wikipedia.
Protected by copyright.
 o
n
 February 25, 2020 at Nord-Trondelag University College.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-028939 on 19 July 2019. Downloaded from 
3Siri SRA, et al. BMJ Open 2019;9:e028939. doi:10.1136/bmjopen-2019-028939
Open access
Sami. Furthermore, we excluded those that did not hand 
in the main questionnaires (SAMINOR 1: n=1; SAMINOR 
2: n=10). This left us with a final sample of 6417 and 5956 
from SAMINOR 1 and SAMINOR 2, respectively, wherein 
3249 participated in both surveys.
Information from questionnaires
Participants were categorised into ethnic groups based on 
information from the following 11 questions, which were 
identical in the two surveys: ‘What language(s) do/did 
you, your parents, and your grandparents use at home?’; 
‘What is your, your father’s, and your mother’s ethnic 
background?’; ‘What do you consider yourself to be?’ The 
response options were ‘Norwegian’, ‘Sami’, ‘Kven’ and 
‘other’ and multiple answers were allowed. Participants 
were defined as Sami if they (1) considered themselves 
to be Sami, or reported a Sami ethnic background for 
themselves, and (2) spoke a Sami language themselves 
or had at least one parent or grandparent that used it at 
home. All others were categorised as non-Sami. Sensitivity 
analyses were performed, in which different ethnic cate-
gorisations were used.
Smoking status was determined by the following ques-
tions, in SAMINOR 1: ‘Are you currently, or were you 
previously a daily smoker?’ (Yes, currently/Yes, previ-
ously/Never); in SAMINOR 2: ‘Have you ever smoked 
daily?’ (Yes/No), and ‘Are you currently a daily smoker?’ 
(Yes/No). Previous and never smokers were categorised 
as non-smokers.
Use of anti-hypertensive drugs was determined by the 
following question: ‘Do you take medication for high 
blood pressure?’ (Currently/Previously, but not now/
Never used). Previous use, never-use and missing values 
were merged into non-use.
In both surveys, participates reported if they ever have 
had myocardial infarctions and age at first time. Positive 
responses to the former, or age reported for first time, 
were considered as having had a myocardial infarction.
Leisure time physical activity was measured in 
SAMINOR 1 by the ‘Saltin-Grimby’ questionnaire.25 
Overall physical activity at current age was measured in 
SAMINOR 2 by a scale ranging from 1 to 10; an instru-
ment validated in middle aged women living in Tromsø, 
Norway.26
Alcohol consumption was measured in SAMINOR 1 by 
asking: ‘How often during the last year have you consumed 
alcohol?’ (Never/Not during the last year/A few times 
during the last year/1 time per month/2–3 times per 
month/1 time per week/2–3 times per week/4–7 times 
per week). To approximate the question in SAMINOR 2, 
we created two categories: never consumed alcohol and 
consumers of alcohol. In SAMINOR 2, alcohol consump-
tion was asked as follows: ‘Do you practice total alcohol 
abstinence?’ (Yes/no).
Education was measured similarly in both surveys by 
years of education. We categorised the item to match 
roughly primary and lower secondary school, upper 
secondary school and higher education: ≤9 years, 10–12 
years and ≥13 years.
Clinical examination
Trained staff conducted the clinical examination. Waist 
circumference was measured at the umbilicus when the 
participant was standing. Blood pressure was measured 
with digital oscillometric devices (SAMINOR 1: DINA-
MAP-R, Criticon, Tampa, Florida, USA; SAMINOR 2: 
CARESCAPE V100 monitor, GE Healthcare, Milwaukee, 
Wisconsin, USA), with the participant in a seated posi-
tion. Following a 2 min rest, three recordings were made 
at 1 min intervals, and the average of the last two measure-
ments was used in the analysis. Participants were consid-
ered to have hypertension if their systolic blood pressure 
was ≥140 mm Hg, or their diastolic blood pressure was 
≥90 mm Hg, or if they reported using anti-hypertensive 
drugs.
In both surveys, non-fasting blood samples were 
collected. The blood samples were left to coagulate for 
a minimum of 30 min, after which they were centrifuged 
and serum was separated within 2 hours. In SAMINOR 1, 
serum was sent by overnight post and analysed consecu-
tively for lipids (total cholesterol, high-density lipoprotein 
(HDL) cholesterol and triglycerides) with an enzymatic 
method (Hitachi 917 auto analyser, Roche Diagnostics, 
Switzerland) at Ullevål University Hospital, Oslo, Norway. 
In SAMINOR 2, serum samples were kept at −20°C before 
they were sent to the biobank at UiT The Arctic University 
of Norway, for further storage at −70°C. The samples were 
analysed in batches during autumn 2014 at the University 
Hospital of North Norway, Tromsø, Norway. Lipids were 
measured with an enzymatic colorimetric method (Cobas 
8000B, Roche Diagnostics GmbH, Mannheim, Germany).
The 10-year absolute risk of fatal or non-fatal AMI or 
CS was estimated by the NORRISK 2 model27 and deter-
mined separately in women and men based on age, total 
cholesterol, HDL cholesterol, smoking status, systolic 
blood pressure and use of anti-hypertensive drugs.
statistical analyses
Statistical analyses were done using STATA V.15.0. Sample 
characteristics were given by sex for Sami and non-Sami 
in SAMINOR 1 and SAMINOR 2: means (SD) of contin-
uous variables and proportions (numbers) of categorical 
variables. In order to account for the partly overlapping 
samples, changes in population average means and 
prevalences of risk factors between SAMINOR 1 and 
SAMINOR 2 were estimated by sex- and ethnicity-specific 
linear or logistic generalised estimating equation regres-
sion models. Assumptions of normality and homoscedas-
ticity were assessed by a visual inspection of residual plots. 
Changes in triglycerides and in the estimated 10-year risk 
of AMI or CS were log-transformed due to skewed distri-
butions. All regression models were adjusted for age, and 
linear models were additionally adjusted for age squared. 
We assessed if changes in outcomes differed by ethnicity 
by including an interaction term between survey and 
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ethnicity in sex-specific models. If the p value for inter-
action was >0.05, the interaction term was excluded from 
the model and an overall sex-specific mean/prevalence 
was reported. In the opposite case, ethnicity-specific 
changes were reported. Marginal means/prevalences 
were estimated at age 57.5 years in women and at 58.2 
years in men, that is, the sex-specific mean ages in the 
overall sample. Two-way graphs illustrate how cardio-
vascular risk factors varied by age, ethnicity and survey 
(online supplementary figures S1 and S2). Potential 
heterogeneity by age in the overall models was assessed 
by comparing two strata divided at sex-specific mean age. 
The terms for interaction between ethnicity and survey 
remained non-significant across age strata for both sexes. 
Hence, we concluded that age did not modify the overall 
estimates of change in cardiovascular risk factors. We 
considered a two-sided p<0.05 to be significant.
Sensitivity analyses were done with same sex-stratified 
generalised estimating equation models by
1. Dividing the study sample into three groups: (1) those 
who reported ‘Sami’ for all 11 questions, (2) who 
reported Sami in 1–10 questions and (3) those who did 
not report Sami on any of the questions (non-Sami) 
(online supplementary tables S1 and S2).
2. Using the original ethnic categorisation, we adjusted 
for geographical regions: (1) Kautokeino and Karasjok, 
(2) Nesseby, Tana and Porsanger, (3) Kåfjord, Lyngen, 
Storfjord, Skånland and Evenes (online supplementa-
ry table S3).
results
Of the total sample, 53.5% were women. In women and 
men, 37.8% and 39.5% were Sami, respectively. The 
mean age was higher in both sexes in SAMINOR 2 than in 
SAMINOR 1. In both surveys, Sami women (table 1) and 
men (table 2) were less physically active, and Sami women 
reported more often to be non-consumers or abstainers 
of alcohol.
Both non-Sami and Sami women had a decline in 
total cholesterol between SAMINOR 1 and SAMINOR 2 
(p<0.001, table 3). The overall change in total cholesterol 
Table 1 Unadjusted means (SD) and proportions (%) of sample characteristics in women aged 40–79 years participating in 
SAMINOR 1 (2003–2004) and SAMINOR 2 (2012–2014)
Ethnicity
SAMINOR 1 (n=3390) SAMINOR 2 (n=3234)
Non-Sami Sami Non-Sami Sami
Proportions, % (n) 64.7 (2193) 35.3 (1197) 59.7 (1929) 40.4 (1305)
Age, mean (SD) 56.5 (10.1) 55.5 (10.2) 59.1 (10.3) 58.6 (10.4)
Self-reported myocardial infarction, % (n)*† 2.6 (58) 1.9 (23) 3.2 (62) 1.8 (23)
Physical activity using ‘Saltin-Grimby’ questionnaire* ‡ ‡
  Reading, watching television or other sedentary 
activity, % (n)
21.3 (415) 27.7 (297) – – 
  Walking, bicycling or moving around in other ways 
at least 4 hours/week, % (n)
68.1 (1330) 61.9 (664) – – 
  Participation in recreational sports, heavy garden 
work, etc. Duration at least 4 hours/week, % (n)
10.3 (200) 9.6 (103) – – 
  Participation in hard training or athletic competitions 
regularly and several times/week, % (n)
0.4 (7) 0.8 (8) – – 
Level of physical activity on a scale from 1 to 10, 
mean (SD)*
‡ ‡ 5.6 (2.1) 5.2 (2.2)
Never consumed alcohol, % (n)* 14.8 (309) 24.5 (279) ‡ ‡
Alcohol abstinence, yes % (n)* ‡ ‡ 18.4 (341) 27.0 (337)
Years of education, mean (SD)* 10.9 (3.8) 10.7 (4.6) 12.2 (4.0) 12.4 (4.5)
  0–9 years education, % (n) 41.7 (864) 43.6 (497) 28.0 (530) 30.3 (385)
  10–12 years education, % (n) 30.2 (626) 23.2 (265) 29.9 (565) 23.2 (295)
  ≥13 years of education, % (n) 28.1 (584) 33.1 (378) 42.1 (797) 46.5 (592)
Region 1: Kautokeino and Karasjok, % (n) 3.8 (84) 44.8 (537) 5.2 (101) 48.4 (631)
Region 2: Nesseby, Tana and Porsanger, % (n) 27.5 (603) 38.3 (458) 30.1 (580) 36.6 (478)
Region 3: Kåfjord, Lyngen, Storfjord, Skånland and 
Evenes, % (n)
68.7 (1506) 16.9 (202) 64.7 (1248) 15.0 (196)
*Based on a lower number due to missing values.
†Measured differently in SAMINOR 1 and SAMINOR 2.
‡Question not posed.
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in women was −0.50 mmol/L. Sami women had lower 
HDL cholesterol and higher triglycerides than non-Sami 
in both surveys (table 3). The change in triglycerides did 
not differ by ethnicity, but the change in HDL cholesterol 
did, with non-Sami showing a minor increase, and Sami 
showing no change.
In both surveys, Sami women had somewhat lower 
blood pressure than non-Sami did (table 3). The overall 
decline in systolic and diastolic blood pressure was 3.6 and 
1.0 mm Hg (both p<0.001), respectively; these changes did 
not differ by ethnicity. Roughly, 23% of women reported 
use of anti-hypertensive drugs, and this did not change 
over time. The prevalence of hypertension declined in a 
similar magnitude in Sami and non-Sami women: by 6.2 
percentage points (p<0.001) (table 3).
Non-Sami and Sami women had a similar increase of 
6.7 cm in mean waist circumference. The prevalence of 
smoking in non-Sami and Sami women declined by 10.0 
and 5.6 percentage points, respectively (both p<0.001); 
this change did not differ by ethnicity. Overall, the odds 
of current smoking declined by 35% (table 3).
The estimated 10-year risk of AMI or CS declined 
between SAMINOR 1 and SAMINOR 2 in both Sami and 
non-Sami women (both p<0.001, table 3), but more so in 
non-Sami.
Between SAMINOR 1 and SAMINOR 2, total choles-
terol declined more in non-Sami than in Sami men (0.60 
vs 0.43 mmol/L; both p<0.001, table 4), and this change 
varied by ethnicity. Between the surveys, Sami men had a 
slight decline in HDL cholesterol (p<0.001) and a slight 
increase in triglycerides (p<0.001); whereas non-Sami 
men had no changes, hence, changes in HDL cholesterol 
and triglyceride differed for Sami and non-Sami (table 4).
In men, the decline in systolic and diastolic blood pres-
sure did not differ by ethnicity (table 4). The overall decline 
in systolic and diastolic blood pressure in men were 3.1 and 
0.7 mm Hg (both p<0.05), respectively. Overall, we found 
an increase in the prevalence of anti-hypertensive drug 
use, from 21.1% to 23.9% in men, which did not differ 
by ethnicity. The prevalence of hypertension remained 
similar in SAMINOR 1 and SAMINOR 2, with roughly half 
of men being considered hypertensive (table 4).
Table 2 Unadjusted means (SD) and proportions (%) of sample characteristics in men aged 40–79 years participating in 
SAMINOR 1 (2003–2004) and SAMINOR 2 (2012–2014)
Ethnicity
SAMINOR 1 (n=3027) SAMINOR 2 (n=2722)
Non-Sami Sami Non-Sami Sami
Proportions, % (n) 62.1 (1881) 37.9 (1146) 58.7 (1597) 41.3 (1125)
Age, mean (SD) 56.5 (9.8) 56.3 (10.1) 60.4 (10.2) 59.8 (10.3)
Self-reported myocardial infarction, % (n)*† 6.9 (130) 6.5 (75) 8.8 (140) 8.1 (91)
Physical activity using ‘Saltin-Grimby’ questionnaire* ‡ ‡
  Reading, watching television or other sedentary 
activity, % (n)
20.2 (351) 24.3 (254) – – 
  Walking, bicycling or moving around in other ways at 
least 4 hours/week, % (n)
59.5 (1034) 53.0 (555) – – 
  Participation in recreational sports, heavy garden work 
etc. Duration at least 4 hours/week, % (n)
18.6 (324) 20.2 (212) – – 
  Participation in hard training or athletic competitions 
regularly and several times/week, % (n)
1.7 (29) 2.5 (26) – – 
Level of physical activity on a scale from 1 to 10, mean 
(SD)*
‡ ‡ 5.2 (2.01) 5.12 (2.16)
Never consumed alcohol, % (n)* 5.4 (99) 4.5 (50) ‡ ‡
Alcohol abstinence, yes % (n)* ‡ ‡ 10.6 (164) 13.4 (150)
Years of education, mean (SD)* 10.9 (3.7) 10.2 (4.1) 11.8 (3.6) 11.4 (3.8)
  0–9 years education, % (n) 39.6 (719) 47.3 (519) 29.7 (467) 36.3 (400)
  10–12 years education, % (n) 32.7 (594) 27.6 (303) 33.1 (520) 30.3 (333)
  ≥13 years of education, % (n) 27.7 (502) 25.1 (276) 37.2 (584) 33.4 (368)
Region 1: Kautokeino and Karasjok, % (n) 3.3 (63) 37.9 (434) 4.6 (73) 42.4 (477)
Region 2: Nesseby, Tana and Porsanger, % (n) 28.9 (543) 39.0 (447) 32.9 (525) 37.2 (419)
Region 3: Kåfjord, Lyngen, Storfjord, Skånland and 
Evenes, % (n)
67.8 (1275) 23.1 (265) 62.6 (999) 20.4 (229)
*Based on a lower number due to missing values.
†Measured differently in SAMINOR 1 and SAMINOR 2.
‡Question not posed.
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Waist circumference increased similarly in Sami 
and non-Sami men, with an overall increase of 5.9 cm 
(p<0.001). The prevalence of smoking declined similarly 
in non-Sami and Sami men, by 12.3 and 10.0 percentage 
points (both p<0.001), respectively. The overall decline in 
the odds of being a smoker was 46%.
The estimated 10-year risk of AMI or CS declined in 
non-Sami and Sami men (both p<0.001, table 4), but not 
differently in the two ethnic groups.
sensitivity analyses
Overall, the sensitivity analyses were consistent with the 
main findings when using a different ethnic categorisa-
tion (online supplementary tables S1 and S2) and when 
adjusting for region (online supplementary table S3).
DIsCussIOn
From SAMINOR 1 (2003–2004) to SAMINOR 2 (2012–
2014), participants from the selected 10 municipalities 
in Northern Norway had a favourable decline in total 
cholesterol, blood pressure, proportion of smokers and 
the estimated 10-year risk of AMI or CS, whereas waist 
circumference increased. The changes in total cholesterol 
(men only), HDL cholesterol (both sexes), triglycerides 
(men only) and the estimated 10-year risk of AMS or CS 
(women only), were statistically significantly different 
between Sami and non-Sami. The odds of anti-hyperten-
sive drug use increased only in men, whereas the prev-
alence of hypertension decreased only in women. To 
our knowledge, there are no other studies in Sápmi that 
explore whether changes in cardiovascular risk factors 
differ between Sami and non-Sami over time.
In both SAMINOR 1 and SAMINOR 2, the participa-
tion rate was lowest among the youngest participants, 
especially young men. In both surveys, less than half of 
those invited participated, hence, selection bias might be 
an issue. Also, as there is no official registry on ethnicity, 
we do not know if non-participation differed by ethnicity. 
It might be expected that Sami would be less willing to 
participate, given the history of assimilation15 and uneth-
ical research.28 On the other hand, as the surveys were 
carried out by a Sami research centre, invitees with Sami 
affiliations might have been more motivated to partic-
ipate. If that is the case, the slightly adverse pattern in 
Sami, might be partly due to a different selection of Sami 
compared with non-Sami participants.
Further, due to design issues of SAMINOR 1,22 the 
study sample included a lower proportion of participants 
from Sami-dominated municipalities in Finnmark, while 
the same municipalities had an overall high response rate 
in SAMINOR 2. This influences the ethnic and regional 
compositions of the two samples, and makes compari-
sons between the surveys challenging. However, when 
using a different categorisation of ethnicity or adjusting 
for region, the results remained consistent with the main 
results. Moreover, generalisation to the entire Sami and 
non-Sami populations in Northern Norway is not advised, 
as only 10 municipalities were included. However, 
assuming a similar response rate in Sami and non-Sami 
participants, we believe the findings are applicable to 
Sami and non-Sami women and men over 50 years of age 
living in the given geographical regions.
The use of antihypertensive drugs increases with age2 
and during 1975–2010, the prevalence of treatment for 
hypertension increased by a factor of four in Norway.29 
In our study, the use of anti-hypertensive drugs in women 
remained similar in the surveys, whereas the prevalence 
of hypertension in women declined, which corresponds 
to a decline that is independent of treatment with anti-hy-
pertensive drugs.2 In men, we observed an increase in the 
use of anti-hypertensive drugs, whereas the prevalence 
of hypertension remained the same, which may indicate 
that treatment with anti-hypertensive drugs could have 
contributed to a decline in blood pressure.
The observed decreases in cholesterol, systolic blood 
pressure and proportion of smokers, and the increase 
in waist circumference, corresponds well with studies in 
Western Europe3 4 6 7 and with national trends.1 2 5 8 11 30 
Possible explanations are changes in lifestyle and diet—
in line with what is observed nationally11—decreases in 
smoking, less occupational physical activity, more frequent 
use of vehicles for transportation, higher consumption 
of fruits and vegetables, lower consumption of saturated 
fats and an assumed lower consumption of salt.31 The 
decrease in systolic blood pressure may have been halted 
due to the increase in obesity over the last decades.32
In a cohort study in Finnmark (1987–2003), based on 
a follow-up of those participating in both the Finnmark 3 
and SAMINOR 1 surveys, Hermansen et al33 observed—
using the same ethnicity definition as in our study—
that changes in cardiovascular risk factors according to 
change in physical activity level occurred independently 
of ethnicity. Similarly, we observed that changes in 
cardiovascular risk factors did not differ substantially 
by ethnicity, only small and probably negligible differ-
ences were observed in total cholesterol and triglycerides 
in men, and in HDL cholesterol in both sexes, which 
suggests that Sami and non-Sami populations overall have 
undergone similar lifestyle changes. This might be consid-
ered unexpected, as Sami may be perceived as distinct 
from non-Sami in terms of diet34 35 and physical activity.33 
A recent study from SAMINOR 2 found that partici-
pants who defined themselves solely as Sami had a lower 
consumption of vegetables, and a higher consumption 
of moose meat, reindeer meat and fat spread on bread 
than non-Sami and those who regard themselves as both 
Sami and non-Sami.34 In SAMINOR 1 (24 municipalities 
included), a higher consumption of unfiltered coffee was 
observed in Sami participants compared with non-Sami 
and Sami of mixed ethnic descent.35 Furthermore, 
unpublished results from SAMINOR 2 (Borch, personal 
communication, 2018), show that, in women, Sami 
ethnicity was associated with lower total physical activity. 
In the cohort study by Hermansen et al, the proportion of 
leisure-time sedentary individuals in Finnmark decreased 
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between 1987 and 2003; however, the proportions who 
were sedentary was higher in Sami than in non-Sami, 
both at baseline and at the end of follow-up.33 Nonethe-
less, evidence of relevant ethnic differences in changes in 
cardiovascular risk factors and estimated 10-year risk of 
AMI and CS, was not found in our study.
The observed decline in cardiovascular risk factors is 
likely to have a beneficial impact on the incidence of 
coronary heart diseases36 and ischaemic stroke37 in this 
population, which is also reflected by a decrease in the 
estimated 10-year risk of AMI or CS. The decrease in risk 
was smaller in Sami than non-Sami women, which might 
be due to the increase in HDL cholesterol in non-Sami 
women. However, the causal effect of low levels of HDL 
cholesterol on cardiovascular disease is debated.38 39
Inuit populations are characterised by a rapid increase 
in obesity, diabetes and hypertension in parallel with 
decreasing physical activity and deterioration of the lipid 
profile.40 On the other hand, decline in smoking and 
alcohol use have been observed.40 But still, there are 
disparities in cardiovascular health between Indigenous 
peoples and their benchmark populations in high-income 
countries.40 41 Our study indicated that such disparities in 
cardiovascular risk factors are not present in the 10 rural 
municipalities in Northern Norway. Previous studies have 
also shown similar burdens of cardiovascular risk factors 
and morbidity among Sami and non-Sami in Norway.17–21 
This might be due to the fact that the non-Sami reference 
population in these studies17–21 lives side by side with the 
Sami in the same rural regions. This is a stark contrast to, 
for instance, the Inuit and reference Danish population, 
who live on different continents. If we had compared the 
Sami in this study to the general Norwegian population, 
we might have found larger differences in cardiovascular 
risk factors, as there are disparities in health issues across 
regions.11 Second, the small or non-existent disparities 
in health between Sami and non-Sami are suggested to 
be due to similar access to healthcare and education,42 
whereas the lack of similar access has been put forward 
as a reason for health disparities between the Inuit and 
their reference population.40 In summary, differences 
in settlement patterns and in the social determinants of 
health challenge our ability to compare our results with 
international data.
We were not able to adjust for lipid-lowering drugs, 
physical activity, coffee and alcohol consumption, affil-
iation with reindeer herding, or diet in our study, as 
questions relating to these items in the two surveys were 
not comparable. Lipid-lowering drugs are estimated to 
account for approximately 20%–30% of the decline in 
total cholesterol over time,5 6 and therefore it is likely 
that some of the decline in cholesterol is due to the use 
of these drugs. The public health relevance of this study 
is that preventive measures aimed to reduce cardiovas-
cular risk seem to have worked independent of ethnicity. 
Nevertheless, further surveillance of cardiovascular risk 
factors is advisable due to the adverse pattern—although 
minor—in Sami compared with non-Sami.
COnClusIOn
From SAMINOR 1 (2003–2004) to SAMINOR 2 (2012–
2014), the population in rural Northern Norway had a 
favourable decline in total cholesterol, blood pressure, 
hypertension (women only), smoking and the estimated 
10-year risk of AMI or CS; however, they had an increase 
in waist circumference. We found only minor differences 
between Sami and non-Sami subjects regarding change 
in cardiovascular risk factors during this period, which 
suggests that the population of Northern Norway have 
had similar changes in lifestyle and diet.
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